Publications by authors named "Matthew Pianko"

Claim this Profile
P
Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma.
Matthew J Pianko, Niodita Gupta-Werner, Bruno Emond, Patrick Lefebvre, Marie-Hélène Lafeuille

Future Sci OA· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current experiences with teclistamab in patients with multiple myeloma and renal impairment.
Meletios A Dimopoulos, Yael C Cohen, Aurore Perrot, Matthew J Pianko, Edward A Faber

Expert Rev Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linvoseltamab in Patients With Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses.
Hans C Lee, Jeffrey A Zonder, Madhav V Dhodapkar, Sundar Jagannath, James E Hoffman, Matthew J Pianko

Clin Lymphoma Myeloma Leuk· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining renal response assessment in monoclonal immunoglobulin deposition disease: Challenges, limitations and need for consensus.
Sabine Karam, Matthew J Pianko, Hani Hassoun

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Omaveloxolone as An Endoplasmic Reticulum Associated Degradation Inhibitor That Induces Early Apoptotic Signaling in Multiple Myeloma.
Erin M Kropp, Sho Matono, Olivia Y Wang, Aaron M Robida, Malathi Kandarpa, Matthew Pianko

bioRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty measures in multiple myeloma: evaluating the impact on outcomes and quality-of-life in clinical trials and real-world practice.
Matthew J Pianko, Hira S Mian, Kelly L Schoenbeck, Tanya M Wildes

Leuk Lymphoma· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement C3d enables cell-mediated immunity capable of distinguishing spontaneously transformed from nontransformed cells.
Jeffrey L Platt, Chong Zhao, Jeffrey Chicca, Matthew J Pianko, Joshua Han

Proc Natl Acad Sci U S A· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial.
Shambavi Richard, Alexander M Lesokhin, Barry Paul, Jonathan L Kaufman, Matthew Pianko

Nat Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis.
Christy J Khouderchah, Madeleine Ochs, Matthew Pianko, Zahra Mahmoudjafari, Jordan Snyder

J Oncol Pharm Pract· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma.
Malin Hultcrantz, Hani Hassoun, Neha Korde, Kylee MacLachlan, Sham Mailankody, Matthew J Pianko

Blood Cancer J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma.
Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Matthew J Pianko

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement C3d enables protective immunity capable of distinguishing spontaneously transformed from non-transformed cells.
Jeffrey L Platt, Chong Zhao, Jeffrey Chicca, Matthew J Pianko, Joshua Han

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colesevelam for Lenalidomide Associated Diarrhea in Patients with Multiple Myeloma.
Malin Hultcrantz, Hani Hassoun, Neha Korde, Kylee Maclachlan, Sham Mailankody, Matthew J Pianko

Res Sq· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide in the treatment of anti-myelin-associated glycoprotein neuropathy: A phase 1 study to identify the maximum tolerated dose.
Amro M Stino, Naresh Bumma, Rachel Smith, Long Davalos, Jeff Allen, Matthew Pianko

Eur J Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Toxicological Role of Aryl Hydrocarbon Receptor in Obesity-Associated Multiple Myeloma Cell Growth and Survival.
Jonathan D Diedrich, Craig E Cole, Matthew J Pianko, Justin A Colacino, Jamie J Bernard

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study.
Hira Mian, Tanya M Wildes, Ravi Vij, Matthew J Pianko, Ajay Major

Blood Cancer J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients.
John Coda, Kadee Raser, Sarah M Anand, Monalisa Ghosh, Kevin Gregg, Matthew J Pianko

Bone Marrow Transplant· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
Matthew J Pianko, Timothy Tiutan, Andriy Derkach, Jessica Flynn, Steven P Salvatore

Am J Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma.
Anisa Bici, Matthew J Pianko, Victoria R Nachar

Leuk Lymphoma· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of diet and antibiotics on gut microbiota and outcomes in patients with multiple myeloma treated with autologous hematopoietic stem cell transplantation.
Matthew J Pianko

Leuk Lymphoma· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets.
Urvi A Shah, Kylee H Maclachlan, Andriy Derkach, Meghan Salcedo, Kelly Barnett, Matthew J Pianko

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation.
Matthew J Pianko, Jonathan L Golob

Cancer Metastasis Rev· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint Blockade in Melanoma Patients With Underlying Chronic Lymphocytic Leukemia.
James W Smithy, Matthew J Pianko, Colleen Maher, Michael A Postow, Alexander N Shoushtari

J Immunother· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myeloma.
Emily Hoylman, Anna Brown, Anthony J Perissinotti, Bernard L Marini, Matthew Pianko

Leuk Lymphoma· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing Drug from Disease by Use of the Hydrashift 2/4 Daratumumab Assay.
Katie L Thoren, Matthew J Pianko, Youssef Maakaroun, C Ola Landgren, Lakshmi V Ramanathan

J Appl Lab Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis